A 56-year-old woman with scleroderma developed rapidly progressive glomerulonephritis with epithelial crescents associated with hemoptysis after 27 months of D-penicillamine therapy and a cumulative dose of 1,200 g.
rapidly progressive glomerulonephritis
D-penicillamine
epithelial crescents
D-penicillamine
hemoptysis
D-penicillamine